O	O	0	18	Lipopolysaccharide	Lipopolysaccharide	B-NP	NN	O	2	SUB	O
O	O	19	21	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	22	23	a	a	B-NP	DT	O	2	PRD	O
O	O	24	30	potent	potent	I-NP	JJ	O	3	NMOD	O
O	O	31	39	monocyte	monocyte	I-NP	NN	O	4	OBJ	O
O	O	39	40	/	/	B-VP	SYM	O	5	NMOD	O
O	O	40	50	macrophage	macrophage	B-NP	NN	B-cell_type	10	NMOD	B-cell_type
O	O	50	51	-	-	I-NP	HYPH	O	10	NMOD	O
O	O	51	59	specific	specific	I-NP	JJ	O	10	NMOD	O
O	O	60	70	stimulator	stimulator	I-NP	NN	O	6	OBJ	O
O	O	71	73	of	of	B-PP	IN	O	10	NMOD	O
O	O	74	79	human	human	B-NP	JJ	O	17	NMOD	O
O	O	80	96	immunodeficiency	immunodeficiency	I-NP	NN	O	17	NMOD	O
O	O	97	102	virus	virus	I-NP	NN	O	17	NMOD	O
O	O	103	107	type	type	I-NP	NN	O	17	NMOD	O
O	O	108	109	1	1	I-NP	CD	O	17	NMOD	O
O	O	110	120	expression	expression	I-NP	NN	O	11	PMOD	O
O	O	120	121	.	.	O	.	O	2	P	O

O	O	123	141	Lipopolysaccharide	Lipopolysaccharide	B-NP	NN	O	6	SUB	O
O	O	142	143	(	(	O	(	O	4	DEP	O
O	O	143	146	LPS	LPS	B-NP	NN	O	4	DEP	O
O	O	146	147	)	)	O	)	O	1	NMOD	O
O	O	148	156	potently	potently	B-ADVP	RB	O	6	VMOD	O
O	O	157	167	stimulates	stimulate	B-VP	VBZ	O	0	ROOT	O
T4	B-Entity	168	173	human	human	B-NP	JJ	O	10	NMOD	O
T4	I-Entity	174	190	immunodeficiency	immunodeficiency	I-NP	NN	O	10	NMOD	O
T4	I-Entity	191	196	virus	virus	I-NP	NN	O	10	NMOD	O
T4	I-Entity	197	201	type	type	I-NP	NN	O	6	OBJ	O
T4	I-Entity	202	203	1	1	I-NP	CD	O	10	NMOD	O
T4	I-Entity	203	204	-	-	I-NP	HYPH	O	15	NMOD	O
T4	I-Entity	204	208	long	long	I-NP	JJ	B-DNA	15	NMOD	B-DNA
T4	I-Entity	209	217	terminal	terminal	I-NP	JJ	I-DNA	15	NMOD	I-DNA
T4	I-Entity	218	224	repeat	repeat	I-NP	NN	I-DNA	24	NMOD	I-DNA
O	O	225	226	(	(	O	(	O	22	DEP	O
T5	B-Entity	226	229	HIV	HIV	B-NP	NN	O	21	NMOD	O
T5	I-Entity	229	230	-	-	B-NP	HYPH	O	21	P	O
T5	I-Entity	230	231	1	1	I-NP	CD	O	21	NMOD	O
T5	I-Entity	231	232	-	-	I-NP	HYPH	O	21	P	O
T5	I-Entity	232	235	LTR	LTR	I-NP	NN	B-DNA	22	DEP	B-DNA
O	O	235	236	)	)	O	)	O	15	NMOD	O
T1	B-Protein	237	240	CAT	CAT	B-NP	NN	O	24	NMOD	O
O	O	241	251	constructs	construct	I-NP	NNS	O	10	NMOD	O
O	O	252	263	transfected	transfecte	B-VP	VBN	O	24	NMOD	O
O	O	264	268	into	into	B-PP	IN	O	25	VMOD	O
O	O	269	277	monocyte	monocyte	B-NP	NN	B-cell_type	33	NMOD	B-cell_type
O	O	277	278	/	/	O	SYM	O	33	P	O
O	O	278	288	macrophage	macrophage	B-NP	NN	B-cell_line	33	NMOD	B-cell_line
O	O	288	289	-	-	I-NP	HYPH	I-cell_line	33	NMOD	I-cell_line
O	O	289	293	like	like	I-NP	JJ	I-cell_line	33	NMOD	I-cell_line
O	O	294	298	cell	cell	I-NP	NN	I-cell_line	33	NMOD	I-cell_line
O	O	299	304	lines	line	I-NP	NNS	I-cell_line	39	NMOD	I-cell_line
O	O	305	308	but	but	B-CONJP	CC	O	39	NMOD	O
O	O	309	312	not	not	I-CONJP	RB	O	34	DEP	O
O	O	313	314	a	a	B-NP	DT	O	39	NMOD	O
O	O	315	316	T	T	I-NP	NN	B-cell_line	39	NMOD	B-cell_line
O	O	317	321	cell	cell	I-NP	NN	I-cell_line	39	NMOD	I-cell_line
O	O	322	326	line	line	I-NP	NN	I-cell_line	26	PMOD	I-cell_line
O	O	326	327	.	.	O	.	O	6	P	O

O	O	328	332	This	This	B-NP	DT	O	2	NMOD	O
O	O	333	339	effect	effect	I-NP	NN	O	3	SUB	O
O	O	340	347	appears	appear	B-VP	VBZ	O	0	ROOT	O
O	O	348	350	to	to	I-VP	TO	O	5	VMOD	O
O	O	351	353	be	be	I-VP	VB	O	3	VMOD	O
O	O	354	362	mediated	mediate	I-VP	VBN	O	5	VC	O
O	O	363	370	through	through	B-PP	IN	O	6	VMOD	O
O	O	371	374	the	the	B-NP	DT	O	9	NMOD	O
O	O	375	384	induction	induction	I-NP	NN	O	7	PMOD	O
O	O	385	387	of	of	B-PP	IN	O	9	NMOD	O
T6	B-Entity	388	395	nuclear	nuclear	B-NP	JJ	B-protein	14	NMOD	B-protein
T6	I-Entity	396	402	factor	factor	I-NP	NN	I-protein	14	NMOD	I-protein
T6	I-Entity	403	408	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T6	I-Entity	409	410	B	B	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	411	412	(	(	O	(	O	20	DEP	O
T7	B-Entity	412	414	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T7	I-Entity	414	415	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T7	I-Entity	415	420	kappa	kappa	I-NP	NN	I-protein	19	NMOD	I-protein
T7	I-Entity	421	422	B	B	I-NP	NN	I-protein	20	DEP	I-protein
O	O	422	423	)	)	O	)	O	14	NMOD	O
O	O	423	424	.	.	O	.	O	3	P	O

O	O	425	440	Electrophoretic	Electrophoretic	B-NP	JJ	O	4	NMOD	O
O	O	441	449	mobility	mobility	I-NP	NN	O	4	NMOD	O
O	O	450	455	shift	shift	I-NP	NN	O	4	NMOD	O
O	O	456	462	assays	assay	I-NP	NNS	O	5	SUB	O
O	O	463	474	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	475	479	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	480	483	LPS	LPS	B-NP	NN	O	8	SUB	O
O	O	484	491	induces	induce	B-VP	VBZ	O	6	SBAR	O
O	O	492	493	a	a	B-NP	DT	O	12	NMOD	O
T8	B-Entity	494	497	DNA	DNA	I-NP	NN	O	12	NMOD	O
O	O	498	505	binding	binding	I-NP	NN	O	12	NMOD	O
O	O	506	514	activity	activity	I-NP	NN	O	8	OBJ	O
O	O	515	532	indistinguishable	indistinguishable	B-ADJP	JJ	O	12	NMOD	O
O	O	533	537	from	from	B-PP	IN	O	13	AMOD	O
T9	B-Entity	538	540	NF	NF	B-NP	NN	B-protein	18	NMOD	B-protein
T9	I-Entity	540	541	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T9	I-Entity	541	546	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T9	I-Entity	547	548	B	B	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	549	551	in	in	B-PP	IN	O	18	NMOD	O
O	O	552	556	U937	U937	B-NP	NN	B-cell_line	25	NMOD	B-cell_line
O	O	557	560	and	and	I-NP	CC	O	25	NMOD	O
O	O	561	564	THP	THP	I-NP	NN	B-cell_line	25	NMOD	B-cell_line
O	O	564	565	-	-	B-NP	HYPH	I-cell_line	25	NMOD	I-cell_line
O	O	565	566	1	1	I-NP	CD	I-cell_line	25	NMOD	I-cell_line
O	O	567	572	cells	cell	I-NP	NNS	I-cell_line	19	PMOD	I-cell_line
O	O	572	573	.	.	O	.	O	5	P	O

O	O	574	577	LPS	LPS	B-NP	NN	O	2	SUB	O
O	O	578	580	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	581	585	also	also	I-VP	RB	O	2	VMOD	O
O	O	586	591	shown	show	I-VP	VBN	O	2	VC	O
O	O	592	594	to	to	I-VP	TO	O	7	VMOD	O
O	O	595	607	dramatically	dramatically	I-VP	RB	O	7	VMOD	O
O	O	608	616	increase	increase	I-VP	VB	O	4	VMOD	O
O	O	617	620	HIV	HIV	B-NP	NN	O	11	NMOD	O
O	O	620	621	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	621	622	1	1	I-NP	CD	O	11	NMOD	O
O	O	623	633	production	production	I-NP	NN	O	7	OBJ	O
O	O	634	638	from	from	B-PP	IN	O	7	VMOD	O
O	O	639	640	a	a	B-NP	DT	O	25	NMOD	O
O	O	641	652	chronically	chronically	I-NP	RB	O	15	AMOD	O
O	O	653	661	infected	infected	I-NP	JJ	O	25	NMOD	O
O	O	662	670	monocyte	monocyte	I-NP	NN	O	25	NMOD	O
O	O	670	671	/	/	B-VP	SYM	O	25	P	O
O	O	671	681	macrophage	macrophage	B-NP	NN	B-cell_type	23	NMOD	B-cell_type
O	O	681	682	-	-	I-NP	HYPH	O	23	NMOD	O
O	O	682	686	like	like	I-NP	JJ	O	23	NMOD	O
O	O	687	693	cloned	clone	I-NP	VBN	O	23	NMOD	O
O	O	694	698	cell	cell	I-NP	NN	O	23	NMOD	O
O	O	699	703	line	line	I-NP	NN	O	25	NMOD	O
O	O	703	704	,	,	O	,	O	25	P	O
O	O	705	707	U1	U1	B-NP	NN	B-cell_line	12	PMOD	B-cell_line
O	O	707	708	,	,	O	,	O	25	P	O
O	O	709	714	which	which	B-NP	WDT	O	25	NMOD	O
O	O	715	723	produces	produce	B-VP	VBZ	O	27	SBAR	O
O	O	724	728	very	very	B-NP	RB	O	30	AMOD	O
O	O	729	732	low	low	I-NP	JJ	O	31	NMOD	O
O	O	733	739	levels	level	I-NP	NNS	O	28	OBJ	O
O	O	740	742	of	of	B-PP	IN	O	31	NMOD	O
O	O	743	746	HIV	HIV	B-NP	NN	O	32	PMOD	O
O	O	746	747	-	-	B-NP	HYPH	O	33	P	O
O	O	747	748	1	1	I-NP	CD	O	33	NMOD	O
O	O	749	751	at	at	B-PP	IN	O	28	VMOD	O
O	O	752	760	baseline	baseline	B-NP	NN	O	36	PMOD	O
O	O	760	761	.	.	O	.	O	2	P	O

O	O	762	765	The	The	B-NP	DT	O	2	NMOD	O
O	O	766	777	stimulation	stimulation	I-NP	NN	O	10	SUB	O
O	O	778	780	of	of	B-PP	IN	O	2	NMOD	O
O	O	781	786	viral	viral	B-NP	JJ	O	5	NMOD	O
O	O	787	797	production	production	I-NP	NN	O	3	PMOD	O
O	O	798	802	from	from	B-PP	IN	O	5	NMOD	O
O	O	803	807	this	this	B-NP	DT	O	9	NMOD	O
O	O	808	812	cell	cell	I-NP	NN	O	9	NMOD	O
O	O	813	817	line	line	I-NP	NN	O	6	PMOD	O
O	O	818	824	occurs	occur	B-VP	VBZ	O	0	ROOT	O
O	O	825	829	only	only	B-SBAR	RB	O	12	DEP	O
O	O	830	832	if	if	I-SBAR	IN	O	10	VMOD	O
O	O	833	838	these	these	B-NP	DT	O	14	NMOD	O
O	O	839	844	cells	cell	I-NP	NNS	O	15	SUB	O
O	O	845	848	are	be	B-VP	VBP	O	12	SBAR	O
O	O	849	856	treated	treat	I-VP	VBN	O	15	VC	O
O	O	857	861	with	with	B-PP	IN	O	16	VMOD	O
T2	B-Protein	862	873	granulocyte	granulocyte	B-NP	NN	B-protein	24	NMOD	B-protein
T2	I-Protein	873	874	/	/	O	SYM	I-protein	24	P	I-protein
T2	I-Protein	874	884	macrophage	macrophage	B-NP	NN	I-protein	21	NMOD	I-protein
T2	I-Protein	885	891	colony	colony	I-NP	NN	I-protein	24	NMOD	I-protein
T2	I-Protein	891	892	-	-	O	HYPH	I-protein	24	NMOD	I-protein
T2	I-Protein	892	903	stimulating	stimulate	B-VP	VBG	I-protein	24	NMOD	I-protein
T2	I-Protein	904	910	factor	factor	B-NP	NN	I-protein	17	PMOD	I-protein
O	O	911	912	(	(	O	(	O	29	DEP	O
T3	B-Protein	912	914	GM	GM	B-NP	NN	B-protein	28	NMOD	B-protein
T3	I-Protein	914	915	-	-	B-NP	HYPH	I-protein	28	P	I-protein
T3	I-Protein	915	918	CSF	CSF	I-NP	NN	I-protein	29	DEP	I-protein
O	O	918	919	)	)	O	)	O	24	NMOD	O
O	O	920	926	before	before	B-PP	IN	O	16	VMOD	O
O	O	927	936	treatment	treatment	B-NP	NN	O	30	PMOD	O
O	O	937	941	with	with	B-PP	IN	O	31	NMOD	O
O	O	942	945	LPS	LPS	B-NP	NN	O	32	PMOD	O
O	O	945	946	.	.	O	.	O	10	P	O

O	O	947	951	This	This	B-NP	DT	O	2	NMOD	O
O	O	952	963	stimulation	stimulation	I-NP	NN	O	8	SUB	O
O	O	964	966	of	of	B-PP	IN	O	2	NMOD	O
O	O	967	970	HIV	HIV	B-NP	NN	O	7	NMOD	O
O	O	970	971	-	-	B-NP	HYPH	O	7	NMOD	O
O	O	971	972	1	1	I-NP	CD	O	7	NMOD	O
O	O	973	983	production	production	I-NP	NN	O	3	PMOD	O
O	O	984	986	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	987	997	correlated	correlate	I-VP	VBN	O	8	VC	O
O	O	998	1002	with	with	B-PP	IN	O	9	VMOD	O
O	O	1003	1005	an	an	B-NP	DT	O	12	NMOD	O
O	O	1006	1014	increase	increase	I-NP	NN	O	23	NMOD	O
O	O	1015	1017	in	in	B-PP	IN	O	12	NMOD	O
O	O	1018	1021	the	the	B-NP	DT	O	15	NMOD	O
O	O	1022	1027	level	level	I-NP	NN	O	13	PMOD	O
O	O	1028	1030	of	of	B-PP	IN	O	15	NMOD	O
O	O	1031	1034	HIV	HIV	B-NP	NN	B-RNA	20	NMOD	B-RNA
O	O	1034	1035	-	-	B-NP	HYPH	I-RNA	20	NMOD	I-RNA
O	O	1035	1036	1	1	I-NP	CD	I-RNA	20	NMOD	I-RNA
O	O	1037	1040	RNA	RNA	I-NP	NN	I-RNA	16	PMOD	I-RNA
O	O	1041	1044	and	and	O	CC	O	23	NMOD	O
O	O	1045	1048	and	and	O	CC	O	23	NMOD	O
O	O	1049	1059	activation	activation	B-NP	NN	O	10	PMOD	O
O	O	1060	1062	of	of	B-PP	IN	O	23	NMOD	O
T10	B-Entity	1063	1065	NF	NF	B-NP	NN	B-protein	28	NMOD	B-protein
T10	I-Entity	1065	1066	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T10	I-Entity	1066	1071	kappa	kappa	I-NP	NN	I-protein	28	NMOD	I-protein
T10	I-Entity	1072	1073	B	B	I-NP	NN	I-protein	24	PMOD	I-protein
O	O	1073	1074	.	.	O	.	O	8	P	O

O	O	1075	1078	LPS	LPS	B-NP	NN	O	2	SUB	O
O	O	1079	1081	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1082	1085	not	not	O	RB	O	2	VMOD	O
O	O	1086	1090	able	able	B-ADJP	JJ	O	2	PRD	O
O	O	1091	1093	to	to	B-VP	TO	O	6	VMOD	O
O	O	1094	1100	induce	induce	I-VP	VB	O	4	AMOD	O
O	O	1101	1104	HIV	HIV	B-NP	NN	O	10	NMOD	O
O	O	1104	1105	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	1105	1106	1	1	I-NP	CD	O	10	NMOD	O
O	O	1107	1117	production	production	I-NP	NN	O	6	OBJ	O
O	O	1118	1120	in	in	B-PP	IN	O	6	VMOD	O
O	O	1121	1122	a	a	B-NP	DT	O	16	NMOD	O
O	O	1123	1129	cloned	clone	I-NP	VBN	B-cell_line	16	NMOD	B-cell_line
O	O	1130	1131	T	T	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	1132	1136	cell	cell	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	1137	1141	line	line	I-NP	NN	I-cell_line	11	PMOD	I-cell_line
O	O	1141	1142	.	.	O	.	O	2	P	O

O	O	1143	1146	The	The	B-NP	DT	O	2	NMOD	O
O	O	1147	1153	effect	effect	I-NP	NN	O	10	SUB	O
O	O	1154	1156	of	of	B-PP	IN	O	2	NMOD	O
O	O	1157	1160	LPS	LPS	B-NP	NN	O	3	PMOD	O
O	O	1161	1163	on	on	B-PP	IN	O	2	NMOD	O
O	O	1164	1167	HIV	HIV	B-NP	NN	O	9	NMOD	O
O	O	1167	1168	-	-	B-NP	HYPH	O	9	NMOD	O
O	O	1168	1169	1	1	I-NP	CD	O	9	NMOD	O
O	O	1170	1181	replication	replication	I-NP	NN	O	5	PMOD	O
O	O	1182	1188	occurs	occur	B-VP	VBZ	O	0	ROOT	O
O	O	1189	1191	at	at	B-PP	IN	O	10	VMOD	O
O	O	1192	1200	picogram	picogram	B-NP	NN	O	15	NMOD	O
O	O	1201	1204	per	per	B-PP	IN	O	12	NMOD	O
O	O	1205	1215	milliliter	milliliter	B-NP	NN	O	13	PMOD	O
O	O	1216	1230	concentrations	concentration	I-NP	NNS	O	11	PMOD	O
O	O	1231	1234	and	and	O	CC	O	10	VMOD	O
O	O	1235	1238	may	may	B-VP	MD	O	10	VMOD	O
O	O	1239	1241	be	be	I-VP	VB	O	17	VC	O
O	O	1242	1252	clinically	clinically	B-ADJP	RB	O	20	AMOD	O
O	O	1253	1264	significant	significant	I-ADJP	JJ	O	18	PRD	O
O	O	1265	1267	in	in	B-PP	IN	O	20	AMOD	O
O	O	1268	1281	understanding	understand	B-VP	VBG	O	21	PMOD	O
O	O	1282	1285	the	the	B-NP	DT	O	24	NMOD	O
O	O	1286	1297	variability	variability	I-NP	NN	O	22	OBJ	O
O	O	1298	1300	of	of	B-PP	IN	O	24	NMOD	O
O	O	1301	1304	the	the	B-NP	DT	O	28	NMOD	O
O	O	1305	1312	natural	natural	I-NP	JJ	O	28	NMOD	O
O	O	1313	1320	history	history	I-NP	NN	O	25	PMOD	O
O	O	1321	1323	of	of	B-PP	IN	O	28	NMOD	O
O	O	1324	1327	HIV	HIV	B-NP	NN	O	33	NMOD	O
O	O	1327	1328	-	-	B-NP	HYPH	O	33	NMOD	O
O	O	1328	1329	1	1	I-NP	CD	O	33	NMOD	O
O	O	1330	1339	infection	infection	I-NP	NN	O	29	PMOD	O
O	O	1339	1340	.	.	O	.	O	10	P	O
